31 related articles for article (PubMed ID: 24378650)
1. Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.
Zhu W; Li X; Zheng G; Bai C; Ji Z; Zhang H; Xing H; Zhang Y; Huo L
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3116-3125. PubMed ID: 37246998
[TBL] [Abstract][Full Text] [Related]
2. Toxicity Assessment of an Anti-Cancer Drug of p-Toluene Sulfonamide in Zebrafish Larvae Based on Cardiovascular and Locomotion Activities.
Young AYW; Audira G; Saputra F; Alos HC; Aventurado CA; Lai YH; Vasquez RD; Hsiao CD; Hung CH
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008997
[TBL] [Abstract][Full Text] [Related]
3. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.
Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398
[TBL] [Abstract][Full Text] [Related]
4. Development of a
Shin UC; Choi JS; Beak YJ; Lee MW; Kim HS; Choi DW; Kim DG; Kim SW
J Labelled Comp Radiopharm; 2021 Mar; 64(3):129-139. PubMed ID: 33119930
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical and medicinal significance of sulfur (S
Zhao C; Rakesh KP; Ravidar L; Fang WY; Qin HL
Eur J Med Chem; 2019 Jan; 162():679-734. PubMed ID: 30496988
[TBL] [Abstract][Full Text] [Related]
6. Cancer radiotheranostics targeting carbonic anhydrase-IX with
Iikuni S; Ono M; Watanabe H; Shimizu Y; Sano K; Saji H
Theranostics; 2018; 8(11):2992-3006. PubMed ID: 29896298
[TBL] [Abstract][Full Text] [Related]
7. Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.
Lau J; Lin KS; Bénard F
Theranostics; 2017; 7(17):4322-4339. PubMed ID: 29158829
[TBL] [Abstract][Full Text] [Related]
8. Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.
Supuran CT
Metabolites; 2017 Sep; 7(3):. PubMed ID: 28926956
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of
Zhang Z; Lau J; Zhang C; Colpo N; Nocentini A; Supuran CT; Bénard F; Lin KS
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):722-730. PubMed ID: 28385087
[TBL] [Abstract][Full Text] [Related]
10. The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
van Kuijk SJ; Gieling RG; Niemans R; Lieuwes NG; Biemans R; Telfer BA; Haenen GR; Yaromina A; Lambin P; Dubois LJ; Williams KJ
PLoS One; 2016; 11(8):e0161040. PubMed ID: 27513947
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
Lv PC; Putt KS; Low PS
Bioconjug Chem; 2016 Jul; 27(7):1762-9. PubMed ID: 27362480
[TBL] [Abstract][Full Text] [Related]
12. Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody molecule.
Honarvar H; Garousi J; Gunneriusson E; Höidén-Guthenberg I; Altai M; Widström C; Tolmachev V; Frejd FY
Int J Oncol; 2015 Feb; 46(2):513-20. PubMed ID: 25434612
[TBL] [Abstract][Full Text] [Related]
13. Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.
Akurathi V; Dubois L; Celen S; Lieuwes NG; Chitneni SK; Cleynhens BJ; Innocenti A; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
Eur J Med Chem; 2014 Jan; 71():374-84. PubMed ID: 24378650
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of
Nakai M; Pan J; Lin KS; Thompson JR; Nocentini A; Supuran CT; Nakabayashi Y; Storr T
J Inorg Biochem; 2018 Aug; 185():63-70. PubMed ID: 29778927
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.
Akurathi V; Dubois L; Lieuwes NG; Chitneni SK; Cleynhens BJ; Vullo D; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
Nucl Med Biol; 2010 Jul; 37(5):557-64. PubMed ID: 20610160
[TBL] [Abstract][Full Text] [Related]
16. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
Pastorek J; Pastorekova S
Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
